I Was Too Late With Device Placement

Similar documents
Case Presentation #1

8th Emirates Cardiac Society Congress in collaboration with ACC Middle East Conference Dubai: October Acute Coronary Syndromes

Management of Acute Shock and Right Ventricular Failure

Management of Cardiogenic Shock. Dr Stephen Pettit, Consultant Cardiologist

Cath Lab Essentials : LV Assist Devices for Hemodynamic Support (IABP, Impella, Tandem Heart, ECMO)

Cardiogenic Shock Protocol

Case - Advanced HF and Shock (INTERMACS 1)

Percutaneous Transapical Access for Thoracic Endovascular Repair

Bridging With Percutaneous Devices: Tandem Heart and Impella

Antonio Colombo. Centro Cuore Columbus and S. Raffaele Scientific Institute, Milan, Italy. Miracor Symposium. Speaker: 15. Parigi: May 16-19, 2017

Mitigating Operator Risk in Complex Interventional Procedures. Tanveer Rab, MD, FACC Ajay Kirtane, MD, FACC Prashant Kaul, MD, FACC

The Optimal Team for 24/7 CCU shock management

Percutaneous Mechanical Circulatory Support Devices

Challenges. 1. Sizing. 2. Proximal landing zone 3. Distal landing zone 4. Access vessels 5. Spinal cord ischemia 6. Endoleak

Prevention and Management of Vascular Complications Related to Transcatheter Aortic Valve Implantation

Cardiogenic Shock in Acute MI

Rationale for Prophylactic Support During Percutaneous Coronary Intervention

Edwards Sapien. Medtronic CoreValve. Inoperable FDA approved High risk: in trials. FDA approved

Who is the high risk patient?

A case of post myocardial infarction ventricular septal rupture CHRISTOFOROS KOBOROZOS, MD

Options for my no option Patients Treating Heart Conditions Via a Tiny Catheter

Rationale for Left Ventricular Support During Percutaneous Coronary Intervention

The Role of Mechanical Circulatory Support in Cardiogenic Shock: When to Utilize

Dr. Jean-Claude Laborde

Intraaortic Balloon Counterpulsation- Supportive Data for a Role in Cardiogenic Shock ( Be Still My Friend )

Arterial Access for Diagnosis and Intervention T-Woei Tan, MD, FACS

Optimal Techniques for Obtaining Large Caliber Arterial Access

BILLING BULLETIN. Re: Interventional Cardiology. Bulletin #: 1. Date Issued: November 10, Background

Mechanics of Cath Lab Support Devices

For Personal Use. Copyright HMP 2013

Experience with percutaneous suture system for larger caliber vascular access Bruno Freitas, Prof., MD

12 Lead ECGs: Ischemia, Injury & Infarction. Kevin Handke NRP, FP-C, CCP, CMTE STEMI Coordinator Flight Paramedic

Percutaneous Mechanical Circulatory Support for Cardiogenic Shock. 24 th Annual San Diego Heart Failure Symposium Ryan R Reeves, MD FSCAI

Ray Matthews MD Professor of Clinical Medicine Chief of Cardiology University of Southern California

Streamlining a TAVR Procedure From screening to post TAVR care Hatim Al Lawati

The Case for Multivessel Revascularization in Shock

Percutaneous Axillary Artery Access For Branch Grafting for complex TAAAs and pararenal AAAs: How to do it safely

ST-Elevation Myocardial Infarction & Cardiogenic Shock. - What Should We Do?

How to do Primary Angioplasty. - Patients with Cardiogenic Shock

TRANSRADIAL PERIPHERAL VASCULAR INTERVENTIONS

SAMPLE EDITION PELVIC AND LOWER EXTREMITY ARTERIES WITH ENDOVASCULAR REVASCULARIZATION. Cardiovascular Illustrations and Guidelines

Bifurcation stenting with BVS

Complicated PTCA of Left Main Total Occlusion in NSTEMI

Extra Corporeal Life Support for Acute Heart failure

Disclosures. Objectives 10/11/17. Short Term Mechanical Circulatory Support for Advanced Cardiogenic Shock. I have no disclosures to report

Endovascular Repair of Aortic Arch/Thoracic Aneurysms: Bolton RelayBranch Device

Mechanics of Cath Lab Support Devices

TRANSCATHETER AORTIC VALVE IMPLANTATION: PSCC EXPERIENCE DR HUSSEIN ALAMRI PSCC RIYADH

(EU), FACC (USA), FSCAI (USA)

AllinaHealthSystem 1

Rajiv Tayal, Humayun Iftikhar, Benjamin LeSar, Rahul Patel, Naveen Tyagi, Marc Cohen, and Najam Wasty

When Aspiration Thrombectomy Does Not Work? A A R O N W O N G N A T I O N A L H E A R T C E N T R E S I N G A P O R E

Cardiogenic Shock. Carlos Cafri,, MD

Catheter selection for transradial angiography and intervention

Bioprosthetic Mitral Valve Dysfunction: Innovation and Evolution of a New Therapeutic Technique

Heart Team For TAVI Who and How?

Gross Anatomy: Upper Extremity Arteries

Periprocedural Myocardial Infarction and Clinical Outcome In Bifurcation Lesion

Percutaneous coronary intervention of RIMA. The real challenge!

Minimalist Transcatheter Aortic Valve Replacement (MA-TAVR)

2/28/2010. Speakers s name: Paul Chiam. I have the following potential conflicts of interest to report: NONE. Antegrade transvenous transseptal route

Rhondalyn C. McLean. 2 ND YEAR RESEARCH ELECTIVE RESIDENT S JOURNAL Volume VII, A. Study Purpose and Rationale

Cordis EXOSEAL Vascular Closure Device

STEMI ST Elevation Myocardial Infarction

DECLARATION OF CONFLICT OF INTEREST

Cardiogenic Shock. Dr. JPS Henriques. Academic Medical Center University of Amsterdam The Netherlands

Form 4: Coronary Evaluation

An Expedient and Versatile Catheter for Primary STEMI Transradial Catheterization/Intervention

Acute dissections of the descending thoracic aorta (Debakey

Case Presentations TAVR: The Good Bad and The Ugly

Intro: Slide 1. Slide 2. Slide 3. Basic understanding of interventional radiology. Gain knowledge of key terms and phrases

Access (Antegrade, Retrograde, Pedal)

Lessons learned From The National PCI Registry

The Study of Anatomical Variations of Axillary Artery - A Case Report

Alternate Vascular Access for TAVR. Gian Paolo Ussia Campus Bio-medico University, Rome Italy

2/26/2013. NCDR.13 Case Scenario Presentation Cath PCI Registry. Disclosures. Objectives. Dashboard Implications of Some Major Metrics

CIPG Transcatheter Aortic Valve Replacement- When Is Less, More?

Recognizing the Need to Support A Failing Right Ventricular Role of Mechanical Support

New Jersey Cardiac Catheterization Data Registry, Version 2.0 (Please report data only for patients 16 years or older.)

in an Unyielding Patient Dr Jason See, Dr Goh Yew Seong, Dr Rohit Khurana Changi General Hospital Singapore

Matching Patient and Pump in the New Era of Percutaneous Mechanical Circulatory Support

Circulatory Support: From IABP to LVAD

LM stenting - Cypher

Relax and Learn At the Farm 2012

Mechanical Cardiac Support in Acute Heart Failure. Michael Felker, MD, MHS Associate Professor of Medicine Director of Heart Failure Research

The catheter-based treatment of valvular disease and aortic

Form 4: Coronary Evaluation

New York Valves Patient focused evidence-based approach. New York City: 6 December Antonio Colombo

Coronary Arteriovenous Malformation presenting as Acute Myocardial Infarction. Choon Ta NG, Aaron WONG, Foong-Koon CHEAH, Chi Keong CHING

CABG Surgery following STEMI

Le# main treatment with Stentys stent. Carlo Briguori, MD, PhD Clinica Mediterranea Naples, Italy

Percutaneous Intervention for totally Occluded Coarctation Of Aorta. John Jose, Vipin Kumar, Ommen K George Dept Of Cardiology

Interventions in the Elderly

Atherosclerotic Heart Disease: Coronary Vessels, EKG Localization of STEMI and Complications/Derivatives for USMLE Step One

Chronic Total Occlusions. Stephen Cook, MD Medical Director, Cardiac Catheterization Laboratory Oregon Heart & Vascular Institute

Impella Ins & Outs. CarVasz November :45 12:15

Radiation Safety Abbott Vascular. All rights reserved.

SCAI Fall Fellows Course Subclavian/Innominate Case Presentation

National Imaging Associates, Inc. Clinical guidelines CARDIAC CATHETERIZATION -LEFT HEART CATHETERIZATION. Original Date: October 2015 Page 1 of 5

TREATMENT OF HIGHER RISK PATIENTS INTRODUCTION TO PROTECTED PCI WITH IMPELLA. IMP v4

Transcription:

SCAI SHOCK 2018 A Team-Based Course On Cardiogenic Shock General Session # 2 Saturday, October 13, 2018 8:39 8:51 AM Boston Park Plaza - Boston, MA I Was Too Late With Device Placement M Chadi Alraies, MD Wayne State University Detroit Medical Center Detroit, Michigan, USA @chadialraies

None Disclosures

62-year-old man with STEMI 62-year-old man with chest pressure PMHx: HTN, DM, PAD, smoking, CKD EKG ST depression in avr on EKG Troponin 1.2 ng/l BP on presentation 90/57 mmhg on dopamine drip Bedside echocardiogram EF 15-20% Cr 1.2 mg/dl

Ilio-femoral angiogram severe PAD

LM and plad disease

LM with left-to-right collaterals

RCA CTO and severe LV dysfunction

Hemodynamic on Dopamine and Norepi MAP (mmhg) 62 CI (L/min/m2) 1.4 CO (L/min) 2.8 RAP/CVP (mmhg) 19 PASP (mmhg) 53 PADP (mmhg) 32 LVEDP (mmhg) 34 CPO (W) 0.38

Hypotension Uptitration of norepinephrine and dopamine

Cardiac arrest

Ilio-femoral angiogram severe PAD

Prevalence of PAD in High Risk Patients More than one third of patients (35%) with severe aortic stenosis evaluated for TAVR had anatomic criteria unfavorable for transfemoral access. Small minimal luminal diameter Severe angulation of the iliac arteries Severe circumferential calcfiication Kurra V. J Thorac Cardiovasc Surg 2009;137:1258-64

Unfavorable Femoral Access Severe PAD Severe tortuosity

Alternative Access For Large Bore Sheath

Transcaval Axillary

Transcaval Pros Accommodate large bore sheaths Can take Impella 5.0 device Overcome severe iliac femoral PAD Overcome small iliac vessels

Transcaval Cons Technically challenging Ideally requires advanced imaging prior to the procedure Lack of dedicated closure device Increased risk of bleeding

Axillary Pros 6 mm diameter Easy to insert Faster insertion time Low bleeding risk Ambulation Emergent procedure Percutaneous solutions to complications Technically less challenging

Axillary Transcaval Cons Lack of dedicated equipment Lack of familiarity of the anatomy for most ICs Difficult room set up (left) Cannot use Impella 5.0 L without surgical cutdown

Severe PAD and looking for alterative

Anatomical Landmarks Anatomical landmark Familiar with AA segments Acromial Posterior circumflex humeral thoracoacromial 1 Subclavian Familiar with AA branches Access point 2 Superior thoracic Lateral to thoracoacromial Medial to the subscapular / circumflex humaral Medial to humeral head Anterior circumflex humeral Brachial 3 Teres major Pectoralis minor Lateral thoracic Subscapular

Anatomical and Angiographic Landmarks Angiographic landmark: lateral to the thoracoacromial artery and medial to the circumflex humeral / subscapular artery Thoracoacromial Costocervical Access point Subscapular Lateral thoracic Superior thoracic

Reasoning for Access Point Landmark Circumflex humeral Thoracoacromial 1. Compressible 2. Far from brachial plexus 3. Lower risk for pneumothorax Subscapular

Back to the case

Left axillary access (angiographic landmarks) Thoracoacromial Circumflex humeral Lateral thoracic Subscapular

Axillary access (angiographic landmarks)

Advancing sheath and Impella Advancing sheath over stiff 0.035-inch wire of choice (Lunderquist, Amplatz Super Stiff, Supra Core). Impella advanced over 0.018 wire under fluoroscopic guidance into the left ventricle

Severe LM disease EBU 3.5 7Fr ProWater wire to LAD

LM CSI atherectomy 1.25 Diamondback 360 Orbital Atherectomy over ViperWire

LM to LAD 3.5x38 DES

LAD and RI kissing

Final Fluoroscopy time: 33 min Contrast: Visipaque 200 ml

2 Days Later MAP (mmhg) 79 CO (L/min) 4.2 RAP/CVP (mmhg) 12 PASP (mmhg) 45 PADP (mmhg) 15 LVEDP (mmhg) 19

Conclusion Weaned off norepinephrine Lactate 1.8 Cr 1.8 Imeplla removed on day # 3 in the cath lab

Dry Closure Appropriately-sized (1:1) 7-10 X 40 mm balloon is used for dry closure The balloon is advanced over the 0.035-inch wire from the femoral sheath and inflated at low pressure (2-4 atmosphere)

Patient discharge to rehab on day # 6

Summary Access Hemodynamics (RHC,BP, LVEDP, CPO) Circulatory Support Coronary perfusion Minimize vasopressors & inotropes (Early) Escalation of MCS

Thank you @chadialraies alraies@hotmail.com